Clinical Trial Update: The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating whether sarpogrelate can prevent contrast-induced nephropathy in patients with chronic kidney disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Seoul National University Boramae Hospital | Conditions: Chronic Kidney Disease | Phase 4 | Status: UNKNOWN